1. Home
  2. ARGX vs RYAAY Comparison

ARGX vs RYAAY Comparison

Compare ARGX & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • RYAAY
  • Stock Information
  • Founded
  • ARGX 2008
  • RYAAY 1985
  • Country
  • ARGX Netherlands
  • RYAAY Ireland
  • Employees
  • ARGX N/A
  • RYAAY N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • RYAAY Air Freight/Delivery Services
  • Sector
  • ARGX Health Care
  • RYAAY Consumer Discretionary
  • Exchange
  • ARGX Nasdaq
  • RYAAY Nasdaq
  • Market Cap
  • ARGX 37.3B
  • RYAAY 24.7B
  • IPO Year
  • ARGX 2017
  • RYAAY 1997
  • Fundamental
  • Price
  • ARGX $665.60
  • RYAAY $42.64
  • Analyst Decision
  • ARGX Strong Buy
  • RYAAY Buy
  • Analyst Count
  • ARGX 20
  • RYAAY 2
  • Target Price
  • ARGX $653.11
  • RYAAY $60.40
  • AVG Volume (30 Days)
  • ARGX 237.6K
  • RYAAY 1.0M
  • Earning Date
  • ARGX 02-27-2025
  • RYAAY 01-27-2025
  • Dividend Yield
  • ARGX N/A
  • RYAAY 3.30%
  • EPS Growth
  • ARGX N/A
  • RYAAY N/A
  • EPS
  • ARGX N/A
  • RYAAY 1.50
  • Revenue
  • ARGX $1,908,659,000.00
  • RYAAY $15,124,470,215.00
  • Revenue This Year
  • ARGX $70.98
  • RYAAY $3.59
  • Revenue Next Year
  • ARGX $51.22
  • RYAAY $7.59
  • P/E Ratio
  • ARGX N/A
  • RYAAY $12.08
  • Revenue Growth
  • ARGX 85.56
  • RYAAY 6.49
  • 52 Week Low
  • ARGX $349.86
  • RYAAY $36.97
  • 52 Week High
  • ARGX $678.21
  • RYAAY $60.32
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 69.97
  • RYAAY 42.39
  • Support Level
  • ARGX $641.80
  • RYAAY $41.05
  • Resistance Level
  • ARGX $637.08
  • RYAAY $45.91
  • Average True Range (ATR)
  • ARGX 14.21
  • RYAAY 0.91
  • MACD
  • ARGX 3.26
  • RYAAY -0.15
  • Stochastic Oscillator
  • ARGX 80.66
  • RYAAY 32.72

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About RYAAY Ryanair Holdings plc

Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,000 flights daily across 200-plus destinations in 40-plus countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volumes, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.

Share on Social Networks: